Does SELINEXOR Cause Diffuse large b-cell lymphoma refractory? 51 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 51 reports of Diffuse large b-cell lymphoma refractory have been filed in association with SELINEXOR (XPOVIO). This represents 0.7% of all adverse event reports for SELINEXOR.
51
Reports of Diffuse large b-cell lymphoma refractory with SELINEXOR
0.7%
of all SELINEXOR reports
13
Deaths
8
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From SELINEXOR?
Of the 51 reports, 13 (25.5%) resulted in death, 8 (15.7%) required hospitalization.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SELINEXOR. However, 51 reports have been filed with the FAERS database.
What Other Side Effects Does SELINEXOR Cause?
Nausea (2,372)
Fatigue (1,795)
Decreased appetite (1,290)
Diarrhoea (1,190)
Plasma cell myeloma (1,046)
Vomiting (860)
Asthenia (794)
Death (761)
Thrombocytopenia (692)
Platelet count decreased (610)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
DOXORUBICIN (345)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
Which SELINEXOR Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
SELINEXOR vs SELPERCATINIB
SELINEXOR vs SELUMETINIB
SELINEXOR vs SEMAGLUTIDE
SELINEXOR vs SEMUSTINE
SELINEXOR vs SENNA LEAF